Multicenter phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer (Study 1): West Japan Thoracic Oncology Group (WJTOG) trial

Author： Sawa Toshiyuki   Yana Takashi   Takada Minoru   Sugiura Takahiko   Kudoh Shinzoh   Kamei Tadashi   Isobe Takeshi   Yamamoto Hidehiko   Yokota Soichiro   Katakami Nobuyuki   Tohda Yuji   Kawakami Akira   Nakanishi Yoichi   Ariyoshi Yutaka  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.24, Iss.2, 2006-03, pp. : 151-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group (WJTOG) study

By Takeda Koji   Takifuji Nobuhide   Negoro Shunichi   Furuse Kiyoyuki   Nakamura Shinichiro   Takada Yoshiki   Hoso Takanobu   Hayasaka Shinichi   Nakano Takashi   Araki Jun   Senba Hiroshi   Iwami Fumiyuki   Yamaji Yasufumi   Fukuoka Masahiro   Ikegami Harumichi  

Investigational New Drugs, Vol. 25, Iss. 4, 2007-08 ,pp. : 377-383

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study

By Yana Takashi   Negoro Shunichi   Takada Minoru   Yokota Soichiro   Takada Yoshiki   Sugiura Takahiko   Yamamoto Hidehiko   Sawa Toshiyuki   Kawahara Masaaki   Katakami Nobuyuki   Ariyoshi Yutaka   Fukuoka Masahiro  

Investigational New Drugs, Vol. 25, Iss. 3, 2007-06 ,pp. : 253-258

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II study of amrubicin, a novel 9-aminoanthracycline, in patients with advanced non-small-cell lung cancer

By Sugiura Takahiko   Ariyoshi Yutaka   Negoro Shunichi   Nakamura Shinichiro   Ikegami Harumichi   Takada Minoru   Yana Takashi   Fukuoka Masahiro  

Investigational New Drugs, Vol. 23, Iss. 4, 2005-08 ,pp. : 331-337

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetic study of the phase III, randomized, double-blind, multicenter trial (TRIBUTE) of paclitaxel and carboplatin combined with erlotinib or placebo in patients with advanced Non-small Cell Lung Cancer (NSCLC)

By Tran Hai   Zinner Ralph   Blumenschein George   Oh Yun   Papadimitrakopoulou Vassiliki   Kim Edward   Lu Charles   Malik Mubashira   Lum Bert   Herbst Roy  

Investigational New Drugs, Vol. 29, Iss. 3, 2011-06 ,pp. : 499-505

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: A Southwest Oncology Group study

By Whitehead Robert   McCoy Sheryl   Macdonald John   Rivkin Saul   Neubauer Marcus   Dakhil Shaker   Lenz Heinz-Josef   Tanaka Michael   Abbruzzese James  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 335-341

Springer Publishing Company

Access to resources Recommend Favorite